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ABSTRACT 
Context: Classical Congenital Adrenal Hyperplasia (CAH) due to 21-hydroxylase deficiency results in 
hormone imbalances present both prenatally and postnatally that may impact the developing brain.  
Objective: To characterize gray matter morphology in the prefrontal cortex and subregion volumes 
of the amygdala and hippocampus in youth with CAH, compared to controls. 
Design: A cross-sectional study of 27 CAH youth (16 female; 12.6 ± 3.4 year) and 35 typically 
developing, healthy controls (20 female; 13.0 ± 2.8 year) with 3-T magnetic resonance imaging scans. 
Brain volumes of interest included bilateral prefrontal cortex, and nine amygdala and six 
hippocampal subregions. Between-subject effects of group (CAH vs control) and sex, and their 
interaction (group-by-sex) on brain volumes were studied, while controlling for intracranial volume 
(ICV) and group differences in body mass index and bone age.  
Results: CAH youth had smaller ICV and increased cerebrospinal fluid volume compared to controls. 
In fully-adjusted models, CAH youth had smaller bilateral, superior and caudal middle frontal 
volumes, and smaller left lateral orbito-frontal volumes compared to controls. Medial temporal lobe 
analyses revealed the left hippocampus was smaller in fully-adjusted models. CAH youth also had 
significantly smaller lateral nucleus of the amygdala and hippocampal subiculum and CA1 
subregions.  
Conclusions: This study replicates previous findings of smaller medial temporal lobe volumes in CAH 
patients, and suggests that lateral nucleus of the amygdala, as well as subiculum and subfield CA1 of 
the hippocampus are particularly affected within the medial temporal lobes in CAH youth.  
Précis: We collected brain scans of 27 youth with classical CAH and 35 healthy controls. Portions of 
the prefrontal cortex, amygdala, and hippocampus were smaller in CAH youth compared to controls.   
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INTRODUCTION 
Classical Congenital Adrenal Hyperplasia (CAH) is most commonly due to a mutation in the 
CYP21A2 gene, affecting 1 in 15,000 live births, and is the most common cause of primary adrenal 
insufficiency in children (1). Inadequate production of cortisol and aldosterone, and overproduction 
of adrenal androgens, starting in the first trimester in utero can manifest in female newborns with 
the severe, classical forms of CAH as masculinized external genitalia (2,3). Given widespread 
expression of androgen and glucocorticoid receptors throughout the brain (4,5), there has been 
interest in understanding how hormonal imbalances related to CAH may impact distinct subregions 
of the developing brain (6). Several studies have begun to examine brain and behavioral alterations 
associated with CAH, with reported differences in emotional and memory processes in CAH patients. 
These include moderate-to-large reductions in short-term and working memory, which involve the 
hippocampus (7,8). Utilizing neuroimaging, smaller amygdala volumes have been reported in 
children with CAH (9), with affected females exhibiting greater amygdala activity during functional 
magnetic resonance imaging (fMRI) emotional tasks (10) compared to control females (11). 
Adolescents with CAH also differ in their aversive ratings of fearful faces (11), exhibit poorer memory 
for negatively valenced stimuli on fMRI as compared to controls (10,12), and have impaired 
motivational inhibition on a reward-based anti-saccade task (13). Higher rates of anxiety 
disorders are also reported in youth with CAH compared to nationwide rates in healthy or other 
chronically ill pediatric populations (14). More recently, women (18-50 years) affected by CAH due to 
21-hydroxylase deficiency were also found to have reduced hippocampal volumes and impaired 
cognitive performance on working memory and processing speed tests (15).  
Both the amygdala and hippocampus are comprised of heterogenous cell types that can be 
categorized into subregions with distinct cytoarchitecture, with previous non-human animal studies 
showing functional differences between the basal and lateral nuclei (which process high-level 
sensory input and emotional regulation) (16,17) and the central and basolateral nuclei (which are 
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involved in reward learning and food intake) (18). Similarly, both structural and functional MRI 
studies have reported that hippocampal subfields, including the CA1, CA3, and dentate gyrus (DG), 
may have different involvement in learning and memory processes (19,20). The amygdala and 
hippocampus have both efferent and afferent connectivity with the prefrontal cortex (PFC), 
ultimately allowing for successful emotional regulation and learning and memory behaviors (21,22). 
However, it has yet to be studied how the distinct subregions of the amygdala and hippocampus are 
affected in patients with CAH. 
The goal of the current study was to utilize state-of-the-art, high-resolution neuroimaging 
techniques to more fully characterize gray matter morphometry of the PFC, hippocampus, and 
amygdala in youth with classical CAH as compared to a control group. CAH provides the opportunity 
to further understand how alterations in prenatal androgen and cortisol deficiency, as well as 
postnatal androgen and glucocorticoid exposure, may impact the developing brain. By combining 3D 
high-resolution T1- and T2-weighted structural sequences, there is substantial improvement of 
structural MRI to capture tissue contrast, which subsequently allows for enhanced segmentation of 
the amygdala into nine distinct subnuclei [lateral nucleus, basal nucleus, accessory basal nucleus, 
anterior amygdaloid area, medial nucleus, cortical nucleus, cortico-amygdaloid transition, and 
paralaminar nucleus] (23) and the hippocampus into six subfields [parasubiculum, presubiculum, 
subiculum, CA1, CA3, and DG] (24).   
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PARTICIPANTS AND METHODS 
Study Participants 
The study was cross-sectional and approved by the Institutional Review Board of the 
University of Southern California (USC) and Children’s Hospital Los Angeles (CHLA). Written consent 
was obtained from all parents or legal guardians, and/or participants, and all minors up to 14 years 
of age gave assent, in accordance with The Code of Ethics of the World Medical Association. 
Participants were recruited via flyers posted at CHLA and Keck School of Medicine of USC, with CAH 
participants recruited from the CHLA CAH Comprehensive Care Center. Health-related exclusionary 
criteria for all participants included prenatal drug or alcohol exposure, premature birth, serious 
medical illness (other than CAH), eating disorders, or psychotropic medication. Participants were 
screened for any significant neurological conditions (e.g., epilepsy and traumatic head injury) and 
psychiatric/developmental disorders (e.g., autism, attention deficit hyperactive disorder, 
schizophrenia, and self-harm tendencies) which, if present, barred participation. Participants were 
also screened for any factors that would prevent proper and safe usage of MRI, such as irremovable 
ferrous materials (e.g., braces), uncorrectable vision impairments (e.g., blind spots and 
colorblindness), need for hearing aids, or claustrophobia. 
We studied a total of 62 children and adolescents between the ages of 8 and 18 years old at 
the time of their visit (Table 1), including 27 participants with classical CAH and 35 healthy controls 
with no significant medical conditions. Youth with CAH had either the salt-wasting (n=25) or simple-
virilizing form (n=2), as diagnosed by positive newborn screen (n=12), or biochemically and/or by 
genotype (n=15; age of testing 11.2 ± 27.4 months). At the time of the study visit, patients with CAH 
were on daily glucocorticoid dosing (16.5 ± 4.7 mg/m2/day) with glucocorticoid dose equivalencies 
calculated based on growth-suppressing effects of longer-acting glucocorticoids compared to 
hydrocortisone (prednisone dose was multiplied by 5 and dexamethasone dose was multiplied by 
80) (25). Almost all patients (n=26) were also treated with fludrocortisone (0.11 ± 0.04 mg/day). 
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7 
Anthropometric measures of height (cm) and weight (kg) were obtained in all participants. 
Pubertal Tanner staging was assessed by a pediatric endocrinologist. Body mass index (BMI) and BMI 
z-score were calculated by SAS based on 2000 Center for Disease Control Growth Chart data (26,27). 
BA advancement can be a marker of prolonged and/or excess exposure to postnatal androgens, and 
the individual’s standard deviation (SD) for bone age (i.e., BA SD) an index of BA advancement as an 
average (mean) for their age and sex (28). A radiograph of the left hand was used to determine bone 
age (BA) using the Greulich-Pyle method (29) and read in a blinded fashion by a single pediatric 
endocrinologist (M.S.K.). BA SD was determined utilizing digital software (30). BA was obtained at 
the time of the study visit, or within several months of the visit if taken for clinical purposes. The 
individuals who had completed growth at the time of the study visit had their BA x-rays reviewed for 
earlier full maturity as adolescents.  
There were no significant differences between the groups in terms of handedness, 
ethnicity/race composition, family income, maternal education, or IQ, as assessed by the Wechsler 
Adult Intelligence Scale (WASI) IV two-subtest test (31). Pubertal development was not significantly 
different between the two groups, although patients with CAH had higher BMI and BMI z-scores, as 
well as BA SD for their chronological age, as compared to control youth. After an overnight fast (12 
h), and prior to routine morning medications in CAH youth, all participants had had their blood 
drawn at the CHLA Clinical Trials Unit for measurement of analytes including: 17-
hydroxyprogesterone, androstenedione, plasma renin activity, and total testosterone by liquid 
chromatography tandem mass spectrometry (Quest Diagnostics Nichols Institute, San Juan 
Capistrano, CA).  
Magnetic Resonance Imaging (MRI) Acquisition  
All images were collected on a Siemens Magnetom Prisma 3 Tesla MRI scanner using a 32-
channel head coil at University of Southern California’s Center for Image Acquisition. T1-weighted 
structural imaging was acquired using a sagittal whole brain MPRAGE sequence (TR = 2400 ms, TE = 
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2.22 ms, flip angle = 8°, BW = 220 Hz/Px, FoV = 256 mm, 208 slices, and 0.8-mm isotropic voxels, 
with a GRAPPA phase-encoding acceleration factor of 2). T2-weighted variable flip angle turbo spin-
echo sequence was also collected (TR = 3200 ms, TE = 563 ms, BW = 744 Hz/Px, FoV = 256 mm, 208 
slices, 0.8-mm isotropic voxels, and 3.52-ms echo spacing, with a GRAPPA phase-encoding 
acceleration factor of 2). Anterior-posterior and posterior-anterior spin echo field maps were also 
obtained (TR = 8000 ms, TE = 66.0 ms, flip angle = 90°, BW = 2290 Hz/Px, FoV = 208 mm, 72 slices, 
and 2.0-mm isotropic voxels, with a multi-band acceleration factor of 1).  A radiologist reviewed all 
scans for incidental findings of gross abnormalities.  
MRI Analysis 
Whole Brain Segmentation  
Structural image processing, including whole brain segmentation with automated labeling of 
different neuroanatomical structures, was performed using FreeSurfer v6.0 
(http://surfer.nmr.mgh.harvard.edu) (32,33). Standard quality control procedures were as follows: 
1) all raw images were visually inspected for motion prior to processing and 2) post-processed 
images were visually inspected by a trained operator for accuracy of segmentation for each scan per 
participant (34). No manual intervention (i.e., subcortical editing) was performed. In addition to total 
gray matter, cerebrospinal fluid (CSF) and intracranial (ICV) volume were extracted as well as five a 
priori prefrontal regions of interest (ROI) using the Desikan-Killiany Atlas, including the superior, 
rostral middle, caudal middle, lateral orbitofrontal, and medial orbitofrontal regions for both the 
right and left hemisphere. 
Amygdala and Hippocampal Segmentation  
Details of the in vivo amygdala probabilistic atlas construction, validation, estimates of 
individual differences, and comparison with previous atlases have been previously published (23). 
Each participant’s image was registered to the CIT168 atlas using a B-spline bivariate symmetric 
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normalization diffeomorphic registration algorithm from ANTs (35). Implementation of the inverse 
diffeomorphism resulted in a probabilistic segmentation of each participant’s left and right total 
amygdala estimates, as well as the following nine distinct bilateral regions of interest (ROI): lateral 
nucleus (LA), dorsal and intermediate divisions of the basolateral nucleus (BLDI), ventral division of 
the basolateral nucleus and paralaminar nucleus (BLVPL), basomedial nucleus (BM), central nucleus 
(CEN), cortical and medial nuclei (CMN), amygdala transition areas (ATA), amygdalostriatal transition 
area (ASTA), and anterior amygdala area (AAA). In the creation and validation of the CIT168 atlas, 
Tyszka, Pauli (23) established that a contrast-to-noise ratio (CNR) > 1 provides a robust estimation of 
the ground truth volumes. Using their established formula, the CNR for our sample was 1.21 and 
1.01 for the T1- and T2-weighted scans suggesting that we had sufficient CNR to establish amygdala 
boundaries using this method.  
T1- and T2-weighted images for each participant were also utilized to quantify six 
hippocampal subfields, including the parasubiculum, presubiculum, subiculum, CA1, CA3, and 
dentate gyrus (DG) using the computational atlas (24) available in FreeSurfer v6.0 (32). This method 
provides hippocampal subfield volumetric measures that more closely align with histological 
measurements, compared to alternative automated segmentation algorithms and previous versions 
of the software (24). 
Apportionment of Subregions within the Amygdala and Hippocampus 
Examining the absolute volumes of amygdala subnuclei and hippocampal subfields was used 
to determine if each subregion within the amygdala and hippocampus is larger or smaller in youth 
with CAH compared to controls. It is also  important to understand what proportion of the amygdala 
is comprised of each of these aforementioned subregions (23), and if the proportion of each 
subregion differs in youth with CAH compared to controls. The relative proportion (or percentage of 
tissue) comprised of each subregions within the amygdala and hippocampus could further assess 
potential group differences in the tissue composition of the amygdala or hippocampus. Thus, we 
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10 
also examined if youth with CAH exhibit differences in the apportionment of subregions within the 
amygdala and hippocampus, compared to control youth, by calculating a relative volume fraction 
(RVF) for each of the nine amygdala and six hippocampal subregions using the following equation: 
subregion volume ÷ total volume of amygdala or hippocampus (23).  
Statistical Analyses 
All data analyses were performed in Rstudio v1.2 (Boston, MA http://www.rstudio.com/) 
using linear multiple regression and linear-mixed models from package nlme v3.1 (https://CRAN.R-
project.org/package=nlme). Given that BMI z-score, BA SD, and ICV were significantly different 
between CAH and control youth (Tables 1 and 2), these variables were included as covariates in all 
subsequent general linear model analyses, in order to reduce the possibility of these group 
differences contributing to variance in brain volumes. Using ICV as a covariate in the model is a 
preferred method to account for differences in overall brain size when examining regional volume 
differences between groups (36,37). Separate multiple regressions were first implemented to 
examine how group, sex, and their interaction (group*sex) predicted CSF and ICV, while controlling 
for BMI z-score and BA SD. In addition, similar models were performed for total gray matter volume, 
each a priori PFC regional volume, and total amygdala and hippocampus volumes for the right and 
left hemispheres, while including the following in the model as covariates: BMI z-score, BA SD, and 
ICV.  
To assess absolute volumes of amygdala subnuclei and hippocampal subfields, separate 
multi-level models were then performed to investigate group (CAH vs control) and group-by-region 
effects for both the absolute volumes of the nine amygdala subnuclei and six hippocampal subfields 
across both hemispheres (right or left as the within-subject variable), while again including the 
following in the model as covariates: BMI z-score, BA SD, and ICV.  
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11 
To assess potential differences in the apportionment of subregions within the amygdala and 
hippocampus, separate multi-level models were again performed to investigate group (CAH vs 
control) and group-by-region effects using the RVFs of the nine amygdala subnuclei and six 
hippocampal subfields across both hemispheres (right or left as the within-subject variable), while 
including BMI z-score and BA SD as covariates. Note, ICV was not included as a covariate in the RVF 
models as these values reflect the proportion of each subregion to the total amygdala or 
hippocampus volume of each individual participant. Post-hoc tests were then performed to probe 
significant interactions (group-by-region), correcting for multiple comparisons using the Holm 
method.  
Lastly, for regions showing significant group differences in brain structure, a within-group 
assessment of relationships between brain structure and clinical features was performed in youth 
with CAH using multiple regression. These clinical features included: BA SD, testosterone and 
androstenedione levels, and glucocorticoid daily dose (mg/m2/day).  
RESULTS 
Radiological Findings 
During radiology review, one CAH patient was found to have a Type 1 Chiari malformation, 
and two CAH patients were found to have arachnoid cysts, with one cyst located near the temporal 
lobe and the other near the cerebellum. Because central nervous system anomalies have been 
previously reported in patients with CAH (15), analyses were performed including these participants; 
however, follow-up analyses were also examined excluding the data from these three patients to 
ensure they were not driving group effects. Sample characteristics were similar between the groups 
when excluding the three CAH patients with brain anomalies. 
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Total Brain Volumes 
A significant main effect was seen for both ICV and CSF, with youth with CAH having smaller 
ICV, but larger CSF volumes, compared to controls (Table 2, Figure 1A and 1B). No significant 
differences were seen in overall cortical gray matter (Figure 1C). For the medial temporal lobe 
volumes, total amygdala and hippocampus volumes were smaller on average in CAH youth 
compared to controls, although in statistical testing only the total left hippocampus volume was 
significantly smaller in CAH (p = 0.01) (Table 2, Figure 2A and B). For the PFC region, the bilateral 
superior frontal, bilateral caudal middle frontal, and left rostral middle frontal regions were 
significantly smaller in CAH youth compared to controls (Table 2, Figure 2C and D). A trend was also 
seen in smaller right lateral orbitofrontal volumes in CAH youth compared to controls, which did not 
reach statistical significance (p = 0.07). Group-by-sex effects were not significant in any of the 
models (data not shown). 
Amygdala Subnuclei and Hippocampal Subfields 
Significant group [F(1,55) = 11.70, p = 0.001, ηp² = 0.006] and group-by-region interactions 
[F(8,1020) = 5.64, p < 0.0001, ηp² = 0.03] were seen in the absolute volumes for amygdala subnuclei 
(Figure 3A). Follow-up post-hoc analyses revealed that the largest amygdala subnucleus, the LA, was 
significantly smaller in CAH patients as compared to controls (Table 3, Figure 3A). No main effect of 
group [F(1,55) = 0.08, p = 0.77, ηp² < 0.001] or group-by-region interaction [F(8,1020) = 1.16, p = 
0.32, ηp² = 0.008] was seen for amygdala RVF (Table 3, Figure 3A).  
Significant group [F(1,56) = 8.99, p = 0.004, ηp² = 0.02] and group-by-region interactions 
[F(5,671) = 7.80, p < 0.0001, ηp² = 0.03] were also seen in the absolute volumes for the hippocampal 
subfields (Figure 3B). Follow-up post-hoc analyses revealed that the subiculum and CA1 subfields 
were significantly smaller in CAH youth compared to controls (Figure 3B, Table 3). For hippocampal 
RVF, the overall main effect of group was not significant [F(1,57) = 1.82, p = 0.18, ηp² = 0.002], but 
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13 
the group-by-region interaction was significant [F(6,671) = 5.07, p < 0.0001, ηp² = 0.03] (Figure 3B, 
Table 4). Specifically, the RVF findings showed that the presubiculum, subiculum, and CA1 were 
proportionately smaller, while the CA3 region was proportionately larger, within the hippocampus in 
patients with CAH compared to controls. Albeit significantly different, the differences in 
apportionment between CAH and control youth were very small in magnitude (<1% difference). 
Brain Volumes and Clinical Features in CAH Youth  
No associations were seen between brain volumes and CAH clinical features (data not 
shown), including markers of androgen excess (e.g., BA SD), total testosterone and androstenedione 
levels, 17-hydroxyprogesterone, or glucocorticoid daily dose (Table 1). 
Finally, sensitivity analyses were performed to ensure findings were robust. Given BMI z-
score and advancement of bone age (i.e., BA SD) were significantly different between CAH youth and 
controls, we included these variables as covariates to reduce the possibility of these group 
differences contributing to the variance in brain volumes between the two groups. However, we also 
performed a separate set of analyses without these covariates and found identical significance for 
results for all region and subregion analyses, with the only exception seen for total gray matter 
volume. Without adjusting for covariates, a significant group effect was seen in total gray matter 
volume (F(1,57)=5.53, p=0.022, ηp² = 0.08), whereas the group effect for the adjusted model with 
covariates was not significant (F(1,55)=1.48, p=0.23, ηp² = 0.02; Table 2). These findings suggest that 
group differences in total gray matter volume in CAH vs control youth are likely explained by their 
greater BMI and advancement of bone age.  Lastly, we also examined significant findings excluding 
the three CAH patients with brain anomalies. Results were nearly identical, although some regions, 
including the total left hippocampus, bilateral superior frontal cortex, and the relative volume 
fraction of CA1, became trend-level, and the left caudal middle frontal cortex was no longer 
significant (Table 5).  
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DISCUSSION 
Our study quantified regional differences in gray matter morphometry of the prefrontal 
cortex, hippocampus, and amygdala in youth affected with classical CAH compared to control youth. 
We found smaller total volumes of the amygdala and hippocampus in CAH youth, similar to prior 
findings (15,38), and expanded upon these findings to show regional volume differences in the 
prefrontal cortex (smaller volumes of the superior and caudal middle frontal cortex), lateral nucleus 
of the amygdala, and subiculum and CA1 subregions of the hippocampus in CAH youth compared to 
controls. We also found CAH youth to have smaller intracranial and increased cerebrospinal fluid 
volumes, signifying overall smaller whole brain volumes as well as regional specific differences in the 
prefrontal and medial temporal lobe regions during childhood and adolescent development. 
Over the last two decades, excluding various case studies (39-41), only a small number of 
experimental MRI studies have examined gray matter volumes in children and adults affected with 
CAH. The first study included 39 patients (3 months to 26 years old), 11 of whom displayed smaller 
temporal lobes on T1- and T2-weighted MRI; albeit the study design did not include a true control 
group (42). Another study quantified total amygdala and hippocampal volumes in children with CAH 
as compared to controls, showing smaller amygdala volumes but no difference in hippocampal 
volumes, in both males and females with CAH (38). These findings are in contrast, however, to a 
more recent study that found only a trend-level difference in the left amygdala and a significantly 
smaller right hippocampus in 19 adult women with CAH compared to unaffected women (15). Of 
note, the latter two studies also reported global level differences in brain structure, including trend-
level differences in total cerebral volume in female youth with CAH (38) and increased CSF in adult 
women with CAH (15). Our findings suggest both smaller intracranial volumes, as well as increased 
CSF, in both males and females with CAH using a higher-resolution MRI scan and both T1- and T2-
weighted images to improve accuracy in quantifying gray and white matter boundaries. Although we 
found that, in general, total bilateral amygdala and hippocampal volumes were smaller in CAH youth 
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compared to controls, the differences in absolute amygdala and hippocampal volumes between CAH 
and control youth may be a consequence of overall smaller brain volumes given that group 
differences exist in ICV. After accounting for smaller ICV in our final models, only the left 
hippocampus was significantly smaller in both males and females with CAH compared to control 
youth, suggesting that differences in the amygdala may be a function of global differences in brain 
volumes, whereas the smaller left hippocampal volume is not a function of the overall difference in 
brain size.  
Our interest in examining the PFC, amygdala, and hippocampus in CAH stems from the high 
concentrations of androgens, as well as mineralocorticoid and glucocorticoid receptors, in these 
neural regions of non-human animals (4,43,44). However, non-human primate and human studies 
suggest both the amygdala and the hippocampal formation have heterogeneous subregions in terms 
of their cytoarchitecture and projections (45,46). A major signaling pathway of the hippocampus, 
known as the perforant path, includes projections from the entorhinal cortex to both the DG and 
CA3, and then onto the CA1, hippocampal subfields. The DG is comprised of dense granule cells that 
send their projections, known as mossy fibers, to CA3, whereas the pyramidal cells in CA3 send their 
axons, known as the Schaffer collaterals, to CA1. The CA1 projects to the subiculum, and is the main 
output of the hippocampus (46). Amygdala nuclei also have distinct connectivity patterns. The 
basolateral portion of the amygdala, including the lateral (LA) and basal (BLDI, BM, and BLVPL 
regions) nuclei, receives sensory and regulatory information from the thalamus and PFC, 
respectively. Within the amygdala, the basolateral nuclei send projections to the central and medial 
nuclei, which project to the hypothalamus and the bed nucleus of the stria terminalis (BNST) (45). 
Moreover, reciprocal connections exist between the hippocampus and amygdala, and the PFC and 
amygdala, with basal nuclei of the amygdala projecting to the entorhinal cortex and PFC, and 
subiculum and CA1 subfields of the hippocampus projecting back to the basolateral amygdala (47). 
Our findings suggest that within these heterogeneous medial temporal lobe structures, the lateral 
nucleus of the amygdala, and the subiculum and CA1 hippocampal subregions are particularly 
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affected in youth with CAH. In addition to overall size differences, the current study also examined 
the relative volume fractions, or the apportionment of subregions within the amygdala and 
hippocampus. The subnuclei within the amygdala were found to be proportionally similar, whereas 
the subfields within the hippocampus were found to be significantly different in proportion, 
between youth with CAH and healthy controls. Specifically, in youth with CAH, the primary output of 
the perforant path (including CA1, presubiculum, and subiculum regions) was disproportionately 
smaller compared to the overall size of the hippocampus, whereas the CA3 region occupied a larger 
proportion of the hippocampus compared to controls. Although the group difference in relative 
proportions for any given hippocampal subfield was small (i.e., <1% difference), these findings 
suggest that, not only are subfield volumes affected, but there are slight differences in the structural 
organization of subfields within the hippocampus, and perhaps even compensatory mechanisms, in 
CAH youth as compared to controls.  
While structure does not necessarily imply function, additional research is needed to 
determine the potential real-world consequences of these structural findings in terms of emotional 
and reward-related behaviors. Since the lateral nuclei act as the major input of information to be 
processed by the amygdala, it is possible that structural differences in this region may reflect altered 
cognitive and sensory integration of emotional stimuli or experiences, which may help to explain 
previously reported differences in subjective ratings of negative stimuli found in CAH patients(11). 
Given the role of the CA1 and subiculum as major outputs of the hippocampus and playing an 
important role in both emotional and non-emotional memory, reduced volumes in these regions 
may also relate to previous findings of poorer memory for negative emotional stimuli (10,12) and 
the moderate-to-large reductions in short-term and working memory abilities seen in individuals 
with CAH (7,8). 
Mechanistically, it remains unclear as to what feature(s) inherent to CAH are responsible for 
decreases in cortical volumes in the prefrontal and medial temporal lobes. CAH includes prenatal 
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgaa023/5707565 by guest on 22 January 2020
Ac
ce
pte
d M
an
us
cri
pt
  
 
17 
glucocorticoid deficiency, excess prenatal and postnatal androgens, and postnatal glucocorticoid 
treatment. Although clinical features have been found to relate to some cognitive tests or other 
brain biomarkers (15), we and others have not yet found markers of glucocorticoid or androgen 
exposure to predict amygdala or hippocampal volumes (15,38). It has also been postulated that high 
levels of androgen exposure prenatally may masculinize brains of females with CAH. However, in our 
study, group differences in brain structure did not significantly differ between the sexes (i.e., 
group*sex interaction terms were not significant in any of our models), suggesting that structural 
differences compared to controls are similar in both males and females with CAH. We and others 
have not found male-sized brain volumes in females with CAH (9), with preserved sexual dimorphism 
in our study in regard to females having smaller gray matter volumes compared to males. These 
findings suggest that the structure of the PFC and medial temporal lobes is not masculinized.  
Instead of resulting from excessive androgen exposure, the smaller amygdala, hippocampus, 
and PFC volumes in both males and females with CAH may be a byproduct of their potentially 
diminished role in neural regulation of the hypothalamic-pituitary-adrenal (HPA) axis, as a result of 
the cortisol deficiency seen in CAH (48). In healthy individuals, cells within the amygdala and 
hippocampus project to the hypothalamus to create a vital negative feedback loop for the HPA-axis 
in response to stress (49). In CAH, perhaps hippocampal and amygdala neurons succumb to the ‘use 
it or lose it’ theory of neuroplasticity, resulting in less synaptic proliferation, or even programmed 
cell death, after failing to establish a typical neurofeedback circuit due to impairments in the HPA 
axis. Support for this hypothesis is evidenced by other pediatric clinical disorders associated with 
HPA dysfunction, such as hypercortisolism (Cushing syndrome), which is also linked to smaller total 
brain volumes, including the amygdala and hippocampus. In addition, suppressed cortisol awakening 
responses have also been associated with smaller PFC and hippocampal volumes in individuals at 
high risk for psychosis based on desensitized HPA responsivity (50). Further support for structural 
brain differences potentially being linked to HPA dysfunction in youth with CAH also stems from 
smaller volumes localized to the subiculum and CA1 hippocampal subfields. The CA1 responds to 
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glucocorticoids in a dose-response fashion and the subiculum plays a key role in inhibiting the HPA 
axis (51,52). Taken together, these data suggest that disruptions of HPA homeostasis may result in 
altered amygdala, hippocampus, and PFC volumes (53). Alternatively, a lack of association between 
brain volumes and exposures due to treatment or hormone concentrations may be muddled by 
individual differences in glucocorticoid-related genes, which may otherwise complicate hormone 
concentrations and clearance, as well as physiological neural responses (54). In addition, neurologic 
impairments, including possible brain injury, may result from adrenal crises associated with CAH 
which merits further study (7). More research is needed to better understand the biological 
mechanisms that may contribute to smaller regional volumes of the amygdala, hippocampus, and 
PFC in youth with CAH.  
Strengths of the current study include the high-resolution T1- and T2- weighted MRI 
approach allowing for more accurate quantification of tissue as well as segmentation of the 
amygdala and hippocampus into distinct subregions. A few limitations should also be noted. 
Although equal or larger than previous studies (15,38), our CAH sample size is still relatively small, 
which may have limited our ability to detect small-to-medium effects. In addition, the composition 
of CAH participants in our study limited our ability to compare salt-wasting vs simple-virilizing forms, 
as the majority of patients were salt-wasters. Other studies have included mostly patients with the 
salt-wasting form (15) which could reflect the distribution of salt-wasting to simple-virilizing in 
clinical CAH populations. In addition, this study compared youth with CAH to youth without a chronic 
medical condition (although with similar age and sex characteristics). Given that youth with classical 
CAH are postnatally treated with glucocorticoids and must receive clinical care over their lifetime, 
additional controls that do not have CAH, but have been exposed to glucocorticoids from an early 
age, may be useful to study. Moving forward, it will be imperative for the field to conduct larger 
studies of patients with CAH, and multiple control groups, in order to better understand how various 
clinical features, including commonly seen brain anomalies, may contribute to neurological 
phenotypes. Previous studies have highlighted an increased prevalence of type 1 Chiari anomalies in 
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patients with CAH (15,42), and treatment regimens as well as adherence to the glucocorticoid 
and/or mineralocorticoid replacement in CAH varies greatly among patients. Pooled MRI studies 
across multiple clinical research centers may ultimately help to better understand both individual 
differences, and common patterns of altered brain structure, by clinical CAH phenotype and 
concurrent brain anomalies. Lastly, the current study was designed to examine structural differences 
in a priori gray matter in CAH vs control youth. However, studies have also suggested impairments in 
white matter (15,42) as well as brain function (7,8,10,11,13), in patients with CAH. Thus, studies are 
currently underway to probe additional potential differences in brain structure and function as a 
focus of future research. 
We conclude that youth affected with classical CAH have overall smaller intracranial volumes 
as well as reduced regional volumes in the prefrontal cortex, amygdala, and hippocampus as 
compared to healthy controls, suggesting brain alterations are associated with CAH during childhood 
and adolescent development. Future studies to determine if volumetric differences in the PFC, 
lateral nucleus of the amygdala, subiculum and CA1 hippocampal subregions map onto physiological 
and behavioral phenotypes are needed in patients with CAH.  
Acknowledgments: The authors gratefully thank all participants and their families. In addition, we 
would like to acknowledge Norma Martinez, Heather Ross, Christina Koppin, Kimberly Felix, Veeraya 
Tanawattanacharoen, and Eva Gabor for assisting with participant recruitment and data collection. 
Finally, we thank CARES Foundation for their ongoing support of the CHLA CAH Comprehensive Care 
Center.   
Funding: This study was supported by National Institutes of Health K01 MH1087610 (MMH), 
R03HD090308 (MMH), and K23HD084735 (MSK), CARES Foundation (MEG and MSK), and the Abell 
Foundation (MEG). 
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgaa023/5707565 by guest on 22 January 2020
Ac
ce
pte
d M
an
us
cri
pt
  
 
20 
Data Availability Statement: Restrictions apply to the availability of data generated or 
analyzed during this study to preserve patient confidentiality or because they were used under 
license. The corresponding author will on request detail the restrictions and any conditions 
under which access to some data may be provided.  D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgaa023/5707565 by guest on 22 January 2020
Ac
ce
pte
d M
an
us
cri
pt
  
 
21 
REFERENCES 
1. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 
2005;365(9477):2125-2136. 
2. Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW. 
Consensus statement on 21-hydroxylase deficiency from the European Society for 
Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm 
Res. 2002;58(4):188-195. 
3. New MI. Diagnosis and management of congenital adrenal hyperplasia. Annu Rev 
Med. 1998;49:311-328. 
4. Nunez JL, Huppenbauer CB, McAbee MD, Juraska JM, DonCarlos LL. Androgen 
receptor expression in the developing male and female rat visual and prefrontal 
cortex. J Neurobiol. 2003;56(3):293-302. 
5. Gray JD, Kogan JF, Marrocco J, McEwen BS. Genomic and epigenomic mechanisms 
of glucocorticoids in the brain. Nat Rev Endocrinol. 2017;13(11):661-673. 
6. Mueller SC. Magnetic resonance imaging in paediatric psychoneuroendocrinology: a 
new frontier for understanding the impact of hormones on emotion and cognition. J 
Neuroendocrinol. 2013;25(8):762-770. 
7. Collaer ML, Hindmarsh PC, Pasterski V, Fane BA, Hines M. Reduced short term 
memory in congenital adrenal hyperplasia (CAH) and its relationship to spatial and 
quantitative performance. Psychoneuroendocrinology. 2016;64:164-173. 
8. Browne WV, Hindmarsh PC, Pasterski V, Hughes IA, Acerini CL, Spencer D, 
Neufeld S, Hines M. Working memory performance is reduced in children with 
congenital adrenal hyperplasia. Horm Behav. 2015;67:83-88. 
9. Merke DP, Fields JD, Keil MF, Vaituzis AC, Chrousos GP, Giedd JN. Children with 
classic congenital adrenal hyperplasia have decreased amygdala volume: potential 
prenatal and postnatal hormonal effects. J Clin Endocrinol Metab. 2003;88(4):1760-
1765. 
10. Mazzone L, Mueller SC, Maheu F, VanRyzin C, Merke DP, Ernst M. Emotional 
memory in early steroid abnormalities: an FMRI study of adolescents with congenital 
adrenal hyperplasia. Dev Neuropsychol. 2011;36(4):473-492. 
11. Ernst M, Maheu FS, Schroth E, Hardin J, Golan LG, Cameron J, Allen R, Holzer S, 
Nelson E, Pine DS, Merke DP. Amygdala function in adolescents with congenital 
adrenal hyperplasia: a model for the study of early steroid abnormalities. 
Neuropsychologia. 2007;45(9):2104-2113. 
12. Maheu FS, Merke DP, Schroth EA, Keil MF, Hardin J, Poeth K, Pine DS, Ernst M. 
Steroid abnormalities and the developing brain: declarative memory for emotionally 
arousing and neutral material in children with congenital adrenal hyperplasia. 
Psychoneuroendocrinology. 2008;33(2):238-245. 
13. Mueller SC, Daniele T, MacIntyre J, Korelitz K, Carlisi C, Hardin MG, Van Ryzin C, 
Merke DP, Ernst M. Incentive processing in Congenital Adrenal Hyperplasia (CAH): 
a reward-based antisaccade study. Psychoneuroendocrinology. 2013;38(5):716-721. 
14. Mueller SC, Ng P, Sinaii N, Leschek EW, Green-Golan L, VanRyzin C, Ernst M, 
Merke DP. Psychiatric characterization of children with genetic causes of 
hyperandrogenism. Eur J Endocrinol. 2010;163(5):801-810. 
15. Webb EA, Elliott L, Carlin D, Wilson M, Hall K, Netherton J, Reed J, Barrett TG, 
Salwani V, Clayden JD, Arlt W, Krone N, Peet AC, Wood AG. Quantitative Brain 
MRI in Congenital Adrenal Hyperplasia: In Vivo Assessment of the Cognitive and 
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgaa023/5707565 by guest on 22 January 2020
Ac
ce
pte
d M
an
us
cri
pt
  
 
22 
Structural Impact of Steroid Hormones. J Clin Endocrinol Metab. 2018;103(4):1330-
1341. 
16. Wan FJ, Swerdlow NR. The basolateral amygdala regulates sensorimotor gating of 
acoustic startle in the rat. Neuroscience. 1997;76(3):715-724. 
17. Schoenbaum G, Chiba AA, Gallagher M. Neural encoding in orbitofrontal cortex and 
basolateral amygdala during olfactory discrimination learning. J Neurosci. 
1999;19(5):1876-1884. 
18. Baxter MG, Murray EA. The amygdala and reward. Nat Rev Neurosci. 
2002;3(7):563-573. 
19. Lacy JW, Yassa MA, Stark SM, Muftuler LT, Stark CE. Distinct pattern separation 
related transfer functions in human CA3/dentate and CA1 revealed using high-
resolution fMRI and variable mnemonic similarity. Learn Mem. 2011;18(1):15-18. 
20. Eldridge LL, Engel SA, Zeineh MM, Bookheimer SY, Knowlton BJ. A dissociation 
of encoding and retrieval processes in the human hippocampus. J Neurosci. 
2005;25(13):3280-3286. 
21. Adolphs R. Neural systems for recognizing emotion. Curr Opin Neurobiol. 
2002;12(2):169-177. 
22. Preston AR, Eichenbaum H. Interplay of hippocampus and prefrontal cortex in 
memory. Curr Biol. 2013;23(17):R764-773. 
23. Tyszka JM, Pauli WM. In vivo delineation of subdivisions of the human amygdaloid 
complex in a high-resolution group template. Human brain mapping. 
2016;37(11):3979-3998. 
24. Iglesias JE, Augustinack JC, Nguyen K, Player CM, Player A, Wright M, Roy N, 
Frosch MP, McKee AC, Wald LL, Fischl B, Van Leemput K, Alzheimer's Disease 
Neuroimaging I. A computational atlas of the hippocampal formation using ex vivo, 
ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI. 
Neuroimage. 2015;115:117-137. 
25. Finkielstain GP, Kim MS, Sinaii N, Nishitani M, Van Ryzin C, Hill SC, Reynolds JC, 
Hanna RM, Merke DP. Clinical characteristics of a cohort of 244 patients with 
congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2012;97(12):4429-4438. 
26. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei 
R, Curtin LR, Roche AF, Johnson CL. 2000 CDC Growth Charts for the United 
States: methods and development. Vital Health Stat 11. 2002(246):1-190. 
27. Prevention CfDCa. A SAS Program for the 2000 CDC Growth Charts (ages 0 to <20 
years). Vol 2019. Atlanta, GA: Division of Nutrition, Physical Activity, and Obesity, 
National Center for Chronic Disease Prevention and Health Promotion, Centers for 
Disease Control and Prevention. 
28. Creo AL, Schwenk WF, 2nd. Bone Age: A Handy Tool for Pediatric Providers. 
Pediatrics. 2017;140(6). 
29. Greulich WW, Pyle SI. Radiologic Atlas of Skeletal Development of the Hand and 
Wrist. 2 ed. California: Stanford University Press. 
30. Gilsanz V, Ratib O. Hand Bone Age: A Digital Atlas of Skeletal Maturity. Germany: 
Springer. 
31. Wechsler D. Wechsler Adult Intelligence Scale. Fourth ed. San Antonio, TX: Pearson. 
32. Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation 
for unbiased longitudinal image analysis. Neuroimage. 2012;61(4):1402-1418. 
33. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, 
Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM. 
Whole brain segmentation: automated labeling of neuroanatomical structures in the 
human brain. Neuron. 2002;33(3):341-355. 
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgaa023/5707565 by guest on 22 January 2020
Ac
ce
pte
d M
an
us
cri
pt
  
 
23 
34. Backhausen LL, Herting MM, Buse J, Roessner V, Smolka MN, Vetter NC. Quality 
Control of Structural MRI Images Applied Using FreeSurfer-A Hands-On Workflow 
to Rate Motion Artifacts. Front Neurosci. 2016;10:558. 
35. Avants BB, Duda JT, Zhang H, Gee JC. Multivariate normalization with symmetric 
diffeomorphisms for multivariate studies. Med Image Comput Comput Assist Interv. 
2007;10(Pt 1):359-366. 
36. O'Brien LM, Ziegler DA, Deutsch CK, Frazier JA, Herbert MR, Locascio JJ. 
Statistical adjustments for brain size in volumetric neuroimaging studies: some 
practical implications in methods. Psychiatry Res. 2011;193(2):113-122. 
37. Sanfilipo MP, Benedict RH, Zivadinov R, Bakshi R. Correction for intracranial 
volume in analysis of whole brain atrophy in multiple sclerosis: the proportion vs. 
residual method. Neuroimage. 2004;22(4):1732-1743. 
38. Merke DP, Fields JD, Keil MF, Vaituzis AC, Chrousos GP, Giedd JN. Children with 
classic congenital adrenal hyperplasia have decreased amygdala volume: potential 
prenatal and postnatal hormonal effects. J Clin Endocrinol Metab. 2003;88(4):1760-
1765. 
39. Mnif MF, Kamoun M, Mnif F, Charfi N, Kallel N, Rekik N, Na eur BB, Fourati H, 
Daoud E, Mnif Z, Sfar MH, Younes-Mhenni S, Sfar MT, Hachicha M, Abid M. Brain 
magnetic resonance imaging findings in adult patients with congenital adrenal 
hyperplasia: Increased frequency of white matter impairment and temporal lobe 
structures dysgenesis. Indian J Endocrinol Metab. 2013;17(1):121-127. 
40. Sinforiani E, Livieri C, Mauri M, Bisio P, Sibilla L, Chiesa L, Martelli A. Cognitive 
and neuroradiological findings in congenital adrenal hyperplasia. 
Psychoneuroendocrinology. 1994;19(1):55-64. 
41. Gaudiano C, Malandrini A, Pollazzon M, Murru S, Mari F, Renieri A, Federico A. 
Leukoencephalopathy in 21-beta hydroxylase deficiency: report of a family. Brain 
Dev. 2010;32(5):421-424. 
42. Nass R, Heier L, Moshang T, Oberfield S, George A, New MI, Speiser PW. Magnetic 
resonance imaging in the congenital adrenal hyperplasia population: increased 
frequency of white-matter abnormalities and temporal lobe atrophy. J Child Neurol. 
1997;12(3):181-186. 
43. Lupien SJ, McEwen BS. The acute effects of corticosteroids on cognition: integration 
of animal and human model studies. Brain Res Brain Res Rev. 1997;24(1):1-27. 
44. Simerly RB, Chang C, Muramatsu M, Swanson LW. Distribution of androgen and 
estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization 
study. J Comp Neurol. 1990;294(1):76-95. 
45. Amaral DG, Price JL, Pikanen A, Carmichael ST. Anatomical organization of the 
primate amygdaloid complex. In: Aggleton JP, ed. The Amygdala: Neurobiological 
Aspects of Emotion, Memory, and Mental Dysfunction. New York: Wiley-Liss; 
1992:1-66. 
46. Duvernoy HM, Francoise C, Risold PY. The Human Hippocampus: Functional 
Anatomy, Vascularization and Serial Sections with MRI. Springer-Verlag Berlin 
Heidelberg. 
47. H.T. B, M.S. F. Fear and Memory: A View of the Hippocampus Through the Lens of 
the Amygdala. In: J. DDK, ed. Space,Time and Memory in the Hippocampal 
Formation. Vienna: Springer; 2014. 
48. Raff H, Sharma ST, Nieman LK. Physiological basis for the etiology, diagnosis, and 
treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and 
congenital adrenal hyperplasia. Compr Physiol. 2014;4(2):739-769. 
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgaa023/5707565 by guest on 22 January 2020
Ac
ce
pte
d M
an
us
cri
pt
  
 
24 
49. Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, Scheimann J, 
Myers B. Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response. 
Compr Physiol. 2016;6(2):603-621. 
50. Valli I, Crossley NA, Day F, Stone J, Tognin S, Mondelli V, Howes O, Valmaggia L, 
Pariante C, McGuire P. HPA-axis function and grey matter volume reductions: 
imaging the diathesis-stress model in individuals at ultra-high risk of psychosis. 
Transl Psychiatry. 2016;6:e797. 
51. O'Mara S. The subiculum: what it does, what it might do, and what neuroanatomy has 
yet to tell us. J Anat. 2005;207(3):271-282. 
52. Tasker JG, Herman JP. Mechanisms of rapid glucocorticoid feedback inhibition of the 
hypothalamic-pituitary-adrenal axis. Stress. 2011;14(4):398-406. 
53. Erickson K, Drevets W, Schulkin J. Glucocorticoid regulation of diverse cognitive 
functions in normal and pathological emotional states. Neurosci Biobehav Rev. 
2003;27(3):233-246. 
54. Nebesio TD, Renbarger JL, Nabhan ZM, Ross SE, Slaven JE, Li L, Walvoord EC, 
Eugster EA. Differential effects of hydrocortisone, prednisone, and dexamethasone on 
hormonal and pharmacokinetic profiles: a pilot study in children with congenital 
adrenal hyperplasia. Int J Pediatr Endocrinol. 2016;2016:17. 
55. Quantitative Imaging Toolkit: Software for Interactive 3D Visualization, Data 
Exploration, and Computational Analysis of Neuroimaging Datasets. 2018. 
 
  
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgaa023/5707565 by guest on 22 January 2020
Ac
ce
pte
d M
an
us
cri
pt
  
 
25 
Figure Legends 
Figure 1. Global brain volumes in youth with classical CAH and in healthy controls. Plots reflect 
means and standard error of volumes for: A) Cerebrospinal fluid (CSF), B) Cortex, gray matter (GM), 
and C) Intracranial volume (ICV). A) CSF is significantly larger in CAH compared to control youth (** p 
 0.01). C) ICV is significantly smaller in CAH compared to control youth (** p  0.01).   
Figure 2. Total amygdala, hippocampus, and prefrontal cortex (PFC) volumes in youth with classical 
CAH and controls by hemisphere. Plots reflect means and standard error of volumes for: A) 
Amygdala, B) Hippocampus, and C) Prefrontal cortex (PFC) regions of interest. A) A trend level 
difference was seen for smaller total right amygdala volumes in CAH compared to control youth (†p = 
0.10). B) Left hippocampus is significantly smaller in CAH compared to control youth (** p  0.01). C) 
Bilateral superior frontal (SF) cortex volumes (* p  0.05) and caudal middle frontal (MF) cortex 
volumes (* p  0.05) were significantly smaller in CAH compared to control youth. Left rostral middle 
frontal volumes were significantly smaller in CAH compared to control youth (** p  0.01). A trend 
level difference was seen for smaller right lateral orbitofrontal cortex (OFC) volumes in CAH 
compared to control youth (†p = 0.07). D) Significant PFC regions of interest mapped to the cortex for 
visualization (dark gray). 
Figure 3. Amygdala subnuclei and hippocampal subfield differences in youth with classical CAH and 
controls. Means and standard errors plotted for absolute (left) and relative volume fraction (RVF; 
right) across: A) Nine amygdala subnuclei, and B) Six hippocampal subfields. A) Absolute lateral 
nucleus of the amygdala (LA) volumes were significantly smaller in CAH as compared to control 
youth (*** p  0.001). B) Absolute subiculum and CA1 volumes were significantly smaller in CAH 
compared to control youth (*p  0.05 and ** p  0.01, respectively). RVFs were also significantly 
smaller for the presubiculum (** p  0.01), subiculum (** p  0.01), and CA1 (* p  0.05) in CAH 
compared to control youth. Relative volume fractions were also significantly larger for the CA3 
subfield (** p  0.01). C) 3D rendering of amygdala (light gray) and hippocampal regions (dark gray) 
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on a representative CAH participant with significantly smaller absolute volumes per region in CAH 
compared to control youth (black). 3D rendering completed using QIT Software (55).  
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Table 1. Study Participant Characteristics for CAH and Control Youth   
 
 CAH (n = 27) Control (n = 35) Group Difference, p-value 
Age, yr 12.63 ± 3.35 13.03 ± 2.79 
CI: -2.0, 1.0; 
t (50.3) = -0.50; p = 0.62 
Biological Sex, n 
Male 11; 
Female 16 
Male 15; 
Female 20 
2(1) = 0.00; p = 1 
Handedness, n 
Right 25; 
Left 2 
Right 30; 
Left 5 
2(1) = 1.97, p = 0.66 
Hispanic/Latino, % 41 57 2(2) =2.53; p = 0.28 
Race, % 
White 44; 
Black 7; 
Asian 4; 
Multi-race 0; 
Not Reported 30 
White 49; 
Black 11; 
Asian 6; 
Multi-race 6; 
Not Reported 20 
2(4) = 2.09; p = 0.72 
Family income, n 
< $49K 11; 
> $49K 14; 
Not Reported 2 
< $49K 15; 
> $49K 19; 
Not Reported 1 
2(1) = 0.00, p = 1 
Maternal Education, yr 
13.85 ± 3.32, 
 n=26 
14.85 ± 3.47, 
n=34 
CI: -2.8, 0.8; 
t (55.1) = 1.14; p = 0.26 
IQ 100.22 ± 16.67 103.03 ± 15.30 
CI: -11.1, 5.5; 
t (53.5) = 0.68; p = 0.50 
BMI (kg/m2) 27.12 ± 7.28 22.52 ± 5.87 
CI: 1.2, 8.0; 
t (49.2) = 2.67; p = 0.009 
BMI z-score 1.61 ± 0.86 0.80 ± 0.95 
CI: 0.3, 1.3; 
t (58.5) = 3.51; p = 0.0009 
Tanner Stage 2.81 ± 1.64 3.31 ± 1.62 
CI: -1.3, 0.3; 
t (55.7) = 1.19; p = 0.24 
Bone Age, yr 13.43 ± 3.00 13.16 ± 2.77 
CI: -1.2, 1.8; 
t (53.7) = 0.36; p = 0.72 
Bone Age SD 1.44 ± 3.10 0.13 ± 0.60 
CI: 0.1, 2.5; 
t (27.5) = 2.16; p = 0.04 
Brain Anomaly, n 
Type 1 Chiari: 1 
Arachnoid cyst: 2 
  
CAH Form, n SW 25; SV 2 --  
Newborn Screen, n Yes 12; No 15 --  
Fludrocortisone Total 
Daily Dose (mg), n=26 
0.11 ± 0.04 
Range: 0.05 - 0.2 
--  
Glucocorticoid Total 
Daily Dose (mg/m2) 
16.5 ± 4.7 
Range: 7.9 - 29.6 
--  
17-OHP (ng/dL)  
[nmol/L] 
3,656 ± 4,694.8 
Range: 44 - 19,966 
[110.8 ± 142.3 
Range: 1.3 - 605] 
--  
Plasma Renin Activity 
(ng/mL/hr and μg/L/hr) 
3.5 ± 2.9 
Range: 0.07 - 11.9 
--  
Androstenedione 
(ng/dL) 
150.5 ± 227.8 
Range: 10 - 881 
--  
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[nmol/L] [5.2 ± 8 
Range: 0.3 - 30.7] 
Testosterone (ng/dL) 
[nmol/L] 
76.5 ± 155.3 
Range: 0.99 - 623 
[2.7 ± 5.4 
Range: 0.03 - 21.6] 
--  
Mean ± SD   D
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Table 2. Brain Volumes Mean and SD for CAH and Control Youth 
 
 CAH Control Group Difference 
F-statistic, p-value  Males Females Males Females 
 
Total Brain Volumes 
ICV‡ 
1559479 ± 
163595.50 
1438723 ± 
157480.10 
1647836 ± 
136404.50 
1515500 ± 
105509.60 
Group: F(1, 55) =6.34, p = 0.01, ηp² 
=0.10 
Sex:  F(1, 55) =10.7, p = 0.002, ηp² 
=0.17 
CSF‡ 
1123.47 ± 
445.98 
1023.49 ± 
187.06 
911.70 ± 
203.93 
812.71 ± 
145.31 
Group: F(1, 56) =6.46, p = 0.01, ηp² 
=0.10 
Sex:  F(1, 56) =2.1, p = 0.16, ηp² =0.04 
Total  
Gray  
Matter† 
605884.30 ± 
58869.03 
541305.40 
± 55596.74 
645383.50 
± 39360.51 
584338.20   
± 40641.82 
Group: F(1, 55) =1.48, p = 0.23, ηp² 
=0.03 
Sex:  F(1, 55) =10.9, p = 0.002, ηp² 
=0.17 
Amygdala† 
Right 
1724.07 ± 
172.76 
1557.87 ± 
212.42 
1873.87 ± 
191.82 
1689.65   ± 
215.5 
Group: F(1, 55) =1.10, p = 0.10, ηp² 
=0.05 
Sex:  F(1, 55) =1.47, p = 0.23, ηp² 
=0.03 
Left 
1516.58 ±  
166.03 
1437.96 ±   
216.11 
1658.45 ±   
176.89 
1551.60 ± 
176.05 
Group: F(1, 55) =1.10, p = 0.30, ηp² 
=0.02 
Sex:  F(1, 55) =0.0004, p = 0.98, 
ηp² <0.0001 
Hippocampus† 
Right 
4069.85 ± 
817.28 
3843.82 ± 
390.82 
4288.53 ± 
337.15 
4136.89 ± 
407.37 
Group: F(1, 55) =2.00, p = 0.16, ηp² 
=0.04 
Sex:  F(1, 55) =1.72, p = 0.20, ηp² 
=0.03 
Left 
3750.32 ± 
323.39 
3662.90 ± 
389.04 
4149.08 ± 
378.19 
3921.53 ± 
362.23 
Group: F(1, 55) =6.97, p = 0.01, ηp² 
=0.11 
Sex:  F(1, 55) =0.94, p = 0.34, ηp² 
=0.02 
Superior Frontal Cortex† 
Right 
35709.82 ± 
4249.97 
31901.44 
± 4740.10 
39502.47 
± 3196.66 
35363.80 ± 
3014.59 
Group: F(1, 55)=5.66, p = 0.02, ηp² = 
0.09 
Sex: F(1, 55)=4.01, p = 0.05, ηp² = 0.07 
Left 
32669.64 ± 
2806.22 
29490.69 
± 4125.43 
35863.13 
± 4071.86 
32581.2 ± 
2958.53 
Group: F(1, 55)=4.36, p = 0.04, ηp² = 
0.07 
Sex: F(1, 55)=3.97, p = 0.05, ηp² = 0.07 
Caudal Middle Frontal Cortex† 
Right 
7700.45 ± 
1681.72 
7104.75 ± 
1613 
8634.20 ± 
1796.09 
8832.15 ± 
1426.20 
Group: F(1, 55)=8.46, p = 0.005, ηp² 
=0.13 
Sex: F(1, 55)=2.92, p = 0.09, ηp² = 0.05 
Left 
8221.09 ± 
1427.20 
7382.88 ± 
1787.81 
9615.33 ± 
1707.55 
8505.9 ± 
1402.16 
Group: F(1, 55)=5.31, p = 0.02, ηp² 
=0.09 
Sex: F(1, 55)=1.44, p = 0.24, ηp² = 0.03 
Rostral Middle Frontal Cortex† 
Right 
15967.36 ± 
2311.01 
13749.25 
± 1837.47 
16691.80 
± 1832.05 
15089.20 ± 
2119.11 
Group: F(1, 55)=0.34, p = 0.56, ηp² 
=0.006 
Sex: F(1, 55)=2.81, p = 0.09, ηp² = 0.05 
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Left 
15490.27 ± 
1944.1 
13004.19 
± 2068.18 
16508 ± 
2409.9 
15561.95 ± 
2010.04 
Group: F(1, 55)=7.18, p = 0.009, ηp² 
=0.12 
Sex: F(1, 55)=0.32, p = 0.58, ηp² = 
0.006 
Medial Orbitofrontal Cortex† 
Right 
5207.55 ± 
694.62 
5035.12 ± 
794.31 
5218.93 ± 
920.63 
5013 ± 
800.24 
Group: F(1, 55)=2.37, p = 0.13, ηp² = 
0.04 
Sex: F(1, 55)=0.91, p = 0.34, ηp² = 0.02 
Left 
5194.27 ± 
1266.51 
5030.06 ± 
563.45 
5319.87 ± 
661.67 
4888.75 ± 
641.86 
Group: F(1, 55)=1.39, p = 0.24, ηp² = 
0.02 
Sex: F(1, 55)=0.04, p = 0.84, ηp² = 
0.0007 
Lateral Orbitofrontal Cortex† 
Right 
11313.73 ±  
1017.28 
10217.62 
±  1261.01 
11351 ±  
1243.4 
10405.1 ±  
868.41 
Group: F(1, 55)=3.28, p = 0.07, ηp² = 
0.06 
Sex: F(1, 55)=2.43, p = 0.12, ηp² = 0.04 
Left 
11154.36 ± 
1196.43 
10356.44 
± 1168.65 
11593 ± 
1159.35 
10690.65 ± 
969.28 
Group: F(1, 55)=0.07, p = 0.79, ηp² 
=0.001 
Sex: F(1, 55)=0.61, p = 0.43, ηp² = 0.01 
ICV (intracranial volume), CSF (cerebrospinal fluid) 
Model† (adjusted means for BMI z-score, Bone Age Standard Deviation, and ICV) 
Model‡ (adjusted means for BMI z-score and Bone Age Standard Deviation) 
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/advance-article-abstract/doi/10.1210/clinem
/dgaa023/5707565 by guest on 22 January 2020
Ac
ce
pte
d M
an
us
cri
pt
  
 
31 
Table 3. Amygdala Subnuclei Mean and SD for CAH and Control Youth 
 
 
CAH (n=26) Control (n=35) 
Group-by-Region 
Post-hoc Test 
 Total RVF Total RVF Total† 
 
Lateral Nucleus (LA) 
Right 307.22 ± 40.84 0.157 ± 0.013 331.86 ± 46.67 0.159 ± 0.012 Meansadj = -18.86, 
2(1) = 24.88; 
p < 0.0001 Left 297.32 ± 42.92 0.157 ± 0.012 318.99 ± 46.3 0.158 ± 0.013 
Basolateral Nucleus (BLDI) 
Right 192.26 ± 22.75 0.098 ± 0.004 202.12 ± 24.55 0.097 ± 0.004 Meansadj = -6.46, 
2(1) = 2.92; p = 0.08 Left 187.24 ± 22.87 0.099 ± 0.005 198.89 ± 23.25 0.099 ± 0.004 
Basomedial Nucleus (BM) 
Right 109.04 ± 17.47 0.056 ± 0.005 114.37 ± 15.76 0.055 ± 0.004 Meansadj = -.79, 
2(1) = 0.44; p = 0.83 Left 106.64 ± 14.14 0.057 ± 0.004 111.48 ± 13.88 0.056 ± 0.006 
Central Nucleus (CEN) 
Right 46.95 ± 8.06 0.024 ± 0.003 49.04 ± 6.95 0.024 ± 0.002 Meansadj = 2.16, 
2(1) = 0.33; p = 0.57 Left 46.28 ± 7.53 0.025 ± 0.003 48.46 ± 6.79 0.025 ± 0.003 
Cortical and Medial Nuclei (CMN) 
Right 151.04 ± 22.24 0.077 ± 0.006 156.99 ± 19.61 0.078 ± 0.007 Meansadj = -3.11, 
2(1) = 0.67; p = 0.41 Left 147.21 ± 19.26 0.078 ± 0.006 156.07 ± 19.44 0.076 ± 0.007 
Ventral Division of BLDI and Paralaminar Nucleus (BLVPL) 
Right 112.21 ± 13.2 0.058 ± 0.005 120.63 ± 16.43 0.058 ± 0.004 Meansadj = -4.39, 
2(1) = 1.35; p = 0.25 Left 111.06 ± 14.55 0.059 ± 0.004 120 ± 15.87 0.060 ± 0.004 
Amygdala Transition Areas (ATA) 
Right 69.98 ± 10.49 0.036 ± 0.004 75.44 ± 12.05 0.037 ± 0.004 Meansadj = -0.60, 
2(1) = 0.25; p = 0.87 Left 67.7 ± 10.61 0.036 ± 0.003 69.63 ± 9.21 0.035 ± 0.003 
Amygdalostriatal Transition Area (ASTA) 
Right 63.48 ± 8.1 0.033 ± 0.004 69.99 ± 9.4 0.034 ± 0.004 Meansadj = -2.18, 
2(1) = 0.33; p = 0.56 Left 63.12 ± 8.6 0.034 ± 0.004 69.56 ± 10.13 0.035 ± 0.004 
Anterior Amygdala Area (AAA) 
Right 61.74 ± 7.92 0.032 ± 0.003 61.44 ± 7.49 0.030 ± 0.003 Meansadj = 3.64, 
2(1) = 0.92; p = 0.34 Left 59.14 ± 6.84 0.032 ± 0.003 60.76 ± 7.66 0.031 ± 0.004 
Total reflects larger or smaller subregion volume; RVF (relative volume fraction) reflects the fraction 
of the total amygdala that is included in this subregion. 
Meansadj† (adjusted means for BMI z-score, Bone Age Standard Deviation, and ICV) 
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Table 4. Hippocampal Subfields Mean and SD for CAH and Control Youth  
 
 CAH 
(n = 27) 
Control 
(n = 35) 
Group-by-Region 
Post-hoc Test 
 Total RVF Total RVF Total† RVF‡ 
 
Parasubiculum 
Right 
69.15 ± 
16.08 
0.021 ± 
0.004 
70.27 ± 
14.83 
0.020 ± 
0.004 
Meansadj = 7.76, 
2(1) = 0.47; 
p = 0.49 
Meansadj= -
0.0008, 
2(1)=0.49; 
p = 0.48 
Left 
68.49 ± 
12.81 
0.022 ± 
0.004 
70.23 ± 
12.14 
0.021 ± 
0.004 
Presubiculum 
Right 
291.48 ± 
67.89 
0.085 ± 
0.007 
319.14 ± 
36.62 
0.089 ± 
0.006 
Meansadj = -20.67, 
2(1) = 3.36; 
p = 0.07 
Meansadj = -0.003, 
2(1) = 7.99; 
p = 0.005 Left 
285.38 ± 
47.4 
0.089 ± 
0.009 
317.45 ± 
36.61 
0.092 ± 
0.005 
Subiculum 
Right 
401.79 ± 
111.56 
0.117 ± 
0.01 
429.61 ± 
55.35 
0.120 ± 
0.007 
Meansadj = -25.76, 
2(1) = 5.22; 
p = 0.02 
Meansadj = -0.003, 
2(1) = 6.29; 
p = 0.01 Left 
381.15 ± 
51.69 
0.119 ± 
0.007 
423.23 ± 
54.67 
0.122 ± 
0.007 
CA1 
Right 
626.94 ± 
107.6 
0.184 ± 
0.009 
666.49 ± 
87.09 
0.185 ± 
0.011 
Meansadj = -42.40, 
2(1) = 14.13; 
p < 0.0002 
Meansadj= -
0.0025, 
2(1)=4.89; 
p = 0.03 
Left 
571.1 ± 
61.85 
0.179 ± 
0.008 
634.74 ± 
82.84 
0.183 ± 
0.009 
CA3 
Right 
227.15 ± 
39.9 
0.067 ± 
0.007 
229.55 ± 
32.18 
0.064 ± 
0.006 
Meansadj = 4.05, 
2(1) = 0.13; 
p = 0.71 
Meansadj = 0.003, 
2(1) = 6.25; 
p = 0.01 Left 
209.96 ± 
24.22 
0.066 ± 
0.006 
217.84 ± 
29.65 
0.063 ± 
0.006 
Dentate Gyrus (DG) 
Right 
289.33 ± 
48.44 
0.085 ± 
0.005 
304.37 ± 
38.47 
0.085 ± 
0.005 
Meansadj = -8.09, 
2(1) = 0.51; 
p = 0.47 
Meansadj = 0.0008, 
2(1) = 0.46; 
p = 0.50 Left 
272.55 ± 
27.73 
0.086 ± 
0.004 
292.08 ± 
35.31 
0.084 ± 
0.004 
Total reflects larger or smaller subregion volume; RVF (relative volume fraction) reflects the fraction 
of the total hippocampus that is included in this subregion. 
Meansadj† (adjusted means for BMI z-score, Bone Age SD, and ICV) 
Meansadj‡ (adjusted means for BMI z-score and Bone Age SD)  
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Table 5. Sensitivity Analyses Excluding Three CAH Patients with Brain Anomalies 
 
Brain Region 
Group Difference, 
p-value 
Intracranial Volume (ICV) 0.008 
Cerebrospinal Fluid (CSF) 0.007 
Left Hippocampus 0.07 
Right Superior Frontal Cortex 0.08 
Left Superior Frontal Cortex 0.09 
Right Caudal Middle Frontal Cortex 0.01 
Left Caudal Middle Frontal Cortex 0.11 
Left Rostral Middle Frontal Cortex 0.02 
Lateral Nucleus (LA) < 0.001 
Subiculum 0.001 
CA1 < 0.001 
Presubiculum Relative Volume Fraction (RVF) 0.001 
Subiculum Relative Volume Fraction (RVF) 0.003 
CA1 Relative Volume Fraction (RVF) 0.07 
CA3 Relative Volume Fraction (RVF) 0.019 
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Figure 1 
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Figure 2 
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Figure 3 
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